Vario Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 94.59%
- Ebitda -18.17%
- Net Worth -1.51%
- Total Assets -13.45%
About Vario Pharma
Vario Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2008 and has a history of 16 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Sarmalkar, Smita Sarmalkar, and Pratibha Tore serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MH2008PTC178540
-
Company No.
178540
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2008
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vario Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sarmalkar
|
Director | 06-Feb-2008 | Current |
|
Smita Sarmalkar
|
Director | 06-Feb-2008 | Current |
|
Pratibha Tore
|
Director | 06-Feb-2008 | Current |
Financial Performance of Vario Pharma.
Vario Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.59% increase in profit. The company's net worth dipped by a decrease of 1.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vario Pharma?
In 2020, Vario Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shriram Medical Services LlpSunil Sarmalkar is a mutual person
-
Soraya Pharma Private Limited
Sunil Sarmalkar is a mutual person
-
T & T Management Services Private Limited
Sunil Sarmalkar and Smita Sarmalkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vario Pharma?
Unlock and access historical data on people associated with Vario Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vario Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vario Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.